Please try another search
PhoenixBio Co., Ltd. provides contract study services for drug discovery and development primarily in Japan. The company uses PXB-mouse, a chimeric mouse with a humanized liver for use in drug development experiments; and in vitro studies using fresh human hepatocytes taken from PXB-cells. The chimeric mouse model with a humanized liver is used for in vivo studies in gene therapeutics, NASH/NAFLD drug development programs, anti-viral therapeutic tests, DMPK/toxicity studies, and custom transplantations. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.
Name | Age | Since | Title |
---|---|---|---|
Masatsugu Ueda | 74 | 2019 | Auditor |
Yoshinori Fujii | 53 | 2016 | Independent Outside Director |
Tomoyo Mukaiya | 63 | 2014 | Executive Director of Research & Development and Director |
Yasuhiro Tamura | 67 | 2014 | Senior MD, Executive Director of Administration & Director |
Kenji Kuramoto | 68 | 2005 | Executive Chairman |
Takashi Shimada | 65 | 2018 | President, CEO & Representative Director |
Hiromi Okano | 55 | 2019 | Auditor |
Motoyasu Ueno | 63 | 2022 | External Auditor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review